Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9526

1

INTRUSION INC Intrusion Inc. Reports Mixed Revenue Performance, Improved Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9527

1

Verde Clean Fuels, Inc. Verde Clean Fuels Reports Operating Losses, Strategic Developments in Clean Fuels Technology Initiatives

Via official filing (AI summary) | 6 months ago | 0 comments

9528

1

Instil Bio, Inc. Instil Bio Reports Improved Financials, Reduced Operating Expenses, and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9529

1

Lexeo Therapeutics, Inc. Lexo Therapeutics Reports Financial Results, Advances Clinical Programs Amid Ongoing Losses

Via official filing (AI summary) | 6 months ago | 0 comments

9530

1

Marathon Bancorp, Inc. /MD/ Marathon Bancorp Reports 102.9% Increase in Net Income, Net Income of $174,907 in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9531

1

Advanced Flower Capital Inc. Advanced Flower Capital Inc. Reports Decline in Revenue and Profitability in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9532

1

Grace Therapeutics, Inc. Grace Therapeutics Reports Financial Results, Focuses on Lead Drug Candidate GTx-104

Via official filing (AI summary) | 6 months ago | 0 comments

9533

1

Clene Inc. Clene Inc. Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9534

1

Liquidia Corp Liquidia Corporation Reports 21% Q3 Revenue Growth, Significant Expenses Increase, and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

9535

1

Aerkomm Inc. Aerkomm Inc. Reports Significant Revenue Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9536

1

Passage BIO, Inc. Passage Bio Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9537

1

Entero Therapeutics, Inc. Entero Therapeutics Reports Improved Financials, Shifts Focus After ImmunogenX Acquisition

Via official filing (AI summary) | 6 months ago | 0 comments

9538

1

Venus Concept Inc. Venus Concept Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9539

1

Fulcrum Therapeutics, Inc. Fulcrum Therapeutics Reports Turnaround in Financial Performance, Net Income of $6.8M for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9540

1

Wag! Group Co. Wag! Group Reports Significant Revenue Decline and Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9541

1

LEXICON PHARMACEUTICALS, INC. Lexicon Pharmaceuticals Reports Significant Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9542

1

Mural Oncology plc Mural Oncology Reports Financial Results, Anticipates Continued Losses Amid Clinical Development Efforts

Via official filing (AI summary) | 6 months ago | 0 comments

9543

1

Unicycive Therapeutics, Inc. Unicycive Therapeutics Reports Improved Liquidity, Reduced Losses, and Advances in Key Drug Candidate

Via official filing (AI summary) | 6 months ago | 0 comments

9544

1

Acrivon Therapeutics, Inc. Acrivon Therapeutics Reports Strong Asset Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9545

1

ARS Pharmaceuticals, Inc. ARS Pharmaceuticals Reports Revenue Growth, Net Loss in Q3 2024 Amid Product Launch and Expansion Efforts

Via official filing (AI summary) | 6 months ago | 0 comments

9546

1

Mastech Digital, Inc. Mastech Digital Reports Significant Financial Improvements in Q3 2024, Net Income Reaches $1.875 Million

Via official filing (AI summary) | 6 months ago | 0 comments

9547

1

LEAP THERAPEUTICS, INC. Leap Therapeutics Reports Financial Results for Q3 2024, Net Loss Decreases Despite Increased Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

9548

1

Hut 8 Corp. Hut 8 Corp. Reports Significant Revenue Growth and Improved Profitability in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9549

1

Jaguar Health, Inc. Jaguar Health Reports 10.5% Revenue Growth, Improved Financial Health in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9550

1

HG Holdings, Inc. HG Holdings Reports Mixed Financial Results, Focuses on Title Insurance Operations Amidst Challenging Economic Conditions

Via official filing (AI summary) | 6 months ago | 0 comments